Merel Smit

Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults

Saskia C. van der Boor, Merel Smit, Stijn W. van Beek et al. · The Lancet Infectious Diseases · 2022 · 41 citations · Full text

Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial

William J. Stone, Almahamoudou Mahamar, Merel Smit et al. · The Lancet Microbe · 2022 · 25 citations · Full text

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines

Julie Van Coillie, Tamás Pongrácz, Tonći Šuštić et al. · iScience · 2023 · 21 citations · Full text

Artemether–lumefantrine with or without single-dose primaquine and sulfadoxine–pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali

Almahamoudou Mahamar, Merel Smit, Koualy Sanogo et al. · The Lancet Microbe · 2024 · 17 citations · Full text

Artemether–lumefantrine–amodiaquine or artesunate–amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial

Almahamoudou Mahamar, Leen N. Vanheer, Merel Smit et al. · The Lancet Microbe · 2024 · 12 citations · Full text